Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Plasma pharmacokinetics and tissue biodistribution of boron following administration of a boronated porphyrin in dogs.

Tibbitts J, Sambol NC, Fike JR, Bauer WF, Kahl SB.

J Pharm Sci. 2000 Apr;89(4):469-77.

PMID:
10737908
2.

Toxicity, biodistribution, and convection-enhanced delivery of the boronated porphyrin BOPP in the 9L intracerebral rat glioma model.

Ozawa T, Afzal J, Lamborn KR, Bollen AW, Bauer WF, Koo MS, Kahl SB, Deen DF.

Int J Radiat Oncol Biol Phys. 2005 Sep 1;63(1):247-52.

PMID:
16111595
3.

Biodistribution of a carborane-containing porphyrin as a targeting agent for Boron Neutron Capture Therapy of oral cancer in the hamster cheek pouch.

Kreimann EL, Miura M, Itoiz ME, Heber E, Garavaglia RN, Batistoni D, Rebagliati RJ, Roberti MJ, Micca PL, Coderre JA, Schwint AE.

Arch Oral Biol. 2003 Mar;48(3):223-32.

PMID:
12648560
4.

Biodistribution of boron in dogs with spontaneous intracranial tumors following borocaptate sodium administration.

Kraft SL, Gavin PR, Leathers CW, DeHaan CE, Bauer WF, Miller DL, Dorn RV 3rd, Griebenow ML.

Cancer Res. 1994 Mar 1;54(5):1259-63.

5.

Porphyrin-mediated boron neutron capture therapy: a preclinical evaluation of the response of the oral mucosa.

Morris GM, Coderre JA, Micca PL, Nawrocky MM, Hopewell JW, Miura M.

Radiat Res. 2005 Jan;163(1):72-8.

PMID:
15606309
6.

Biodistribution of boron compounds in an animal model of human undifferentiated thyroid cancer for boron neutron capture therapy.

Dagrosa MA, Viaggi M, Rebagliati RJ, Batistoni D, Kahl SB, Juvenal GJ, Pisarev MA.

Mol Pharm. 2005 Mar-Apr;2(2):151-6.

PMID:
15804189
7.

Porphyrin-mediated boron neutron capture therapy: evaluation of the reactions of skin and central nervous system.

Morris GM, Coderre JA, Hopewell JW, Micca PL, Nawrocky M, Miura M.

Int J Radiat Biol. 2003 Mar;79(3):149-58.

PMID:
12745879
8.

Boron biodistribution in beagles after intravenous infusion of 4-dihydroxyborylphenylalanine-fructose complex.

Kulvik ME, Vähätalo JK, Benczik J, Snellman M, Laakso J, Hermans R, Järviluoma E, Rasilainen M, Färkkilä M, Kallio ME.

Appl Radiat Isot. 2004 Nov;61(5):975-9.

PMID:
15308178
9.

Boron neutron capture therapy of brain tumors: biodistribution, pharmacokinetics, and radiation dosimetry sodium borocaptate in patients with gliomas.

Goodman JH, Yang W, Barth RF, Gao Z, Boesel CP, Staubus AE, Gupta N, Gahbauer RA, Adams DM, Gibson CR, Ferketich AK, Moeschberger ML, Soloway AH, Carpenter DE, Albertson BJ, Bauer WF, Zhang MZ, Wang CC.

Neurosurgery. 2000 Sep;47(3):608-21; discussion 621-2.

PMID:
10981748
10.

Toxicology of a boronated porphyrin in dogs.

Tibbitts J, Fike JR, Lamborn KR, Bollen AW, Kahl SB.

Photochem Photobiol. 1999 May;69(5):587-94.

PMID:
10333766
11.

Borocaptate sodium: a potential boron delivery compound for boron neutron capture therapy evaluated in dogs with spontaneous intracranial tumors.

Kraft SL, Gavin PR, DeHaan CE, Leathers CW, Bauer WF, Miller DL, Dorn RV 3rd.

Proc Natl Acad Sci U S A. 1992 Dec 15;89(24):11973-7.

12.

Disposition and tissue distribution of boron after infusion of borocaptate sodium in patients with malignant brain tumors.

Horn V, Slánský J, Janku I, Strouf O, Sourek K, Tovarys F.

Int J Radiat Oncol Biol Phys. 1998 Jun 1;41(3):631-8.

PMID:
9635713
13.

Enhanced boron uptake in RG 2 rat gliomas by electropermeabilization in vivo--a new possibility in boron neutron capture therapy.

Ceberg CP, Brun A, Mir LM, Persson BR, Salford LG.

Anticancer Drugs. 1994 Aug;5(4):463-6.

PMID:
7949252
14.

Boron neutron capture therapy of intracerebral melanoma using boronophenylalanine as a capture agent.

Matalka KZ, Bailey MQ, Barth RF, Staubus AE, Soloway AH, Moeschberger ML, Coderre JA, Rofstad EK.

Cancer Res. 1993 Jul 15;53(14):3308-13.

15.

The hamster cheek pouch as a model of oral cancer for boron neutron capture therapy studies: selective delivery of boron by boronophenylalanine.

Kreimann EL, Itoiz ME, Dagrosa A, Garavaglia R, Farías S, Batistoni D, Schwint AE.

Cancer Res. 2001 Dec 15;61(24):8775-81.

16.

Pharmacokinetics of sodium borocaptate: a critical assessment of dosing paradigms for boron neutron capture therapy.

Gibson CR, Staubus AE, Barth RF, Yang W, Ferketich AK, Moeschberger MM.

J Neurooncol. 2003 Mar-Apr;62(1-2):157-69.

PMID:
12749711
17.

Optimization of boron neutron capture therapy for the treatment of undifferentiated thyroid cancer.

Dagrosa MA, Thomasz L, Longhino J, Perona M, Calzetta O, Blaumann H, Rebagliati RJ, Cabrini R, Kahl S, Juvenal GJ, Pisarev MA.

Int J Radiat Oncol Biol Phys. 2007 Nov 15;69(4):1059-66.

PMID:
17967301
18.

Synthesis and biological evaluation of new boron-containing chlorin derivatives as agents for both photodynamic therapy and boron neutron capture therapy of cancer.

Asano R, Nagami A, Fukumoto Y, Miura K, Yazama F, Ito H, Sakata I, Tai A.

Bioorg Med Chem Lett. 2014 Mar 1;24(5):1339-43. doi: 10.1016/j.bmcl.2014.01.054. Epub 2014 Jan 29.

PMID:
24508130
19.

Boron delivery with liposomes for boron neutron capture therapy (BNCT): biodistribution studies in an experimental model of oral cancer demonstrating therapeutic potential.

Heber EM, Kueffer PJ, Lee MW Jr, Hawthorne MF, Garabalino MA, Molinari AJ, Nigg DW, Bauer W, Hughes AM, Pozzi EC, Trivillin VA, Schwint AE.

Radiat Environ Biophys. 2012 May;51(2):195-204. doi: 10.1007/s00411-011-0399-0. Epub 2012 Jan 21.

PMID:
22271404
20.

Boron neutron capture synovectomy (BNCS) as a potential therapy for rheumatoid arthritis: boron biodistribution study in a model of antigen-induced arthritis in rabbits.

Trivillin VA, Abramson DB, Bumaguin GE, Bruno LJ, Garabalino MA, Monti Hughes A, Heber EM, Feldman S, Schwint AE.

Radiat Environ Biophys. 2014 Nov;53(4):635-43. doi: 10.1007/s00411-014-0564-3. Epub 2014 Aug 26.

PMID:
25156017

Supplemental Content

Support Center